MLTX SECURITIES NEWS: MoonLake Immunotherapeutics (NASDAQ: MLTX) Faces Securities Fraud Allegations after Stock Drops 90% -- Contact BFA Law by December 15 Class Action Deadline

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in MoonLake, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/moonlake-immunotherapeutics. Investors have until December 15, 2025, to ask the Court to be app ...